Dealmaking in 2009: A Look Back and A Glance Ahead

This article was excerpted from "Top Device Stories of 2009: A Year of Economic Revival and Regulatory Risk," IN VIVO, January 2010.

by Stephen Levin

While pundits and commentators debated, more broadly, whether the decade of the 2000s was the worst in history, there's little doubt that 2009—the long 2009 that began in the fourth quarter of 2008—was the most taxing year the medical device industry has faced in a long time. Short of a handful of executives at a handful of companies that saw big deals—Medtronic CoreValve LLC/Medtronic PLC, Evalve Inc./Abbott Laboratories Inc., Acclarent Inc./Johnson & Johnson, to name only three—most device executives found the going tough as public and private investors grew nervous and corporate acquirers sat back, for the most part, waiting to see what the year would bring

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight